Different Effects of RNAi-Mediated Downregulation or Chemical Inhibition of NAMPT in an Isogenic IDH Mutant and Wild-Type Glioma Cell Model.
IDH1 mutation
NAD+ synthesis
glioma
nicotinamide phosphoribosyltransferase
redox household
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
21 May 2022
21 May 2022
Historique:
received:
13
04
2022
revised:
13
05
2022
accepted:
13
05
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
1
6
2022
Statut:
epublish
Résumé
The IDH1
Identifiants
pubmed: 35628596
pii: ijms23105787
doi: 10.3390/ijms23105787
pmc: PMC9143996
pii:
doi:
Substances chimiques
Cytokines
0
NAD
0U46U6E8UK
NADP
53-59-8
Isocitrate Dehydrogenase
EC 1.1.1.41
IDH1 protein, human
EC 1.1.1.42.
Nicotinamide Phosphoribosyltransferase
EC 2.4.2.12
nicotinamide phosphoribosyltransferase, human
EC 2.4.2.12
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Else Kröner-Fresenius-Stiftung
ID : Else Kröner-Promotionskolleg Dresden (M.C.)
Organisme : German Cancer Aid
ID : #70112014
Références
Br J Cancer. 2011 Mar 15;104(6):968-70
pubmed: 21326241
Cell Mol Life Sci. 2013 Jun;70(12):2175-90
pubmed: 23307072
Cancers (Basel). 2019 Dec 16;11(12):
pubmed: 31888244
Neoplasia. 2013 Oct;15(10):1151-60
pubmed: 24204194
PLoS One. 2012;7(6):e40195
pubmed: 22768255
Life Sci. 2017 Nov 1;188:26-36
pubmed: 28864225
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Acta Neuropathol. 2017 Feb;133(2):263-282
pubmed: 28074274
Cancer Biol Ther. 2008 May;7(5):663-8
pubmed: 18728403
Tumour Biol. 2014 Jun;35(6):5911-20
pubmed: 24590270
Acta Neuropathol. 2020 Dec;140(6):919-949
pubmed: 33009951
Nat Rev Cancer. 2012 Nov;12(11):741-52
pubmed: 23018234
J Biol Chem. 2013 Feb 1;288(5):3500-11
pubmed: 23239881
Neoplasia. 2013 Dec;15(12):1314-29
pubmed: 24403854
J Clin Neurosci. 2018 Aug;54:7-13
pubmed: 29801989
Front Public Health. 2016 Jul 21;4:151
pubmed: 27493936
PLoS One. 2013;8(3):e59773
pubmed: 23527265
PLoS One. 2017 Jan 4;12(1):e0169038
pubmed: 28052098
Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):E8247-E8256
pubmed: 27930300
Genes Cancer. 2013 Nov;4(11-12):447-56
pubmed: 24386506
Nature. 2012 Feb 15;483(7390):484-8
pubmed: 22343896
Mol Cell Biol. 2009 Nov;29(21):5872-88
pubmed: 19703994
Curr Opin Gastroenterol. 2007 Mar;23(2):164-70
pubmed: 17268245
Cancer Res. 2003 Nov 1;63(21):7436-42
pubmed: 14612543
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
Nature. 2009 Dec 10;462(7274):739-44
pubmed: 19935646
Nat Commun. 2017 Oct 20;8(1):1067
pubmed: 29057925
Nat Genet. 2008 Oct;40(10):1230-4
pubmed: 18806796
Cancer Cell. 2015 Dec 14;28(6):773-784
pubmed: 26678339
EMBO Mol Med. 2017 Dec;9(12):1681-1695
pubmed: 29054837
Small. 2017 Jul;13(27):
pubmed: 28544767
Cancer Cell. 2010 Dec 14;18(6):553-67
pubmed: 21130701
Acta Neuropathol. 2010 Apr;119(4):487-94
pubmed: 20127344
Neuro Oncol. 2011 Oct;13(10):1074-89
pubmed: 21788344
Curr Neurol Neurosci Rep. 2013 May;13(5):345
pubmed: 23532369
Cancer Res. 2015 Nov 15;75(22):4790-802
pubmed: 26363012
Metabolism. 2018 May;82:72-87
pubmed: 29330025
Oncotarget. 2017 Aug 28;8(59):99514-99530
pubmed: 29245920
Cancer Treat Res. 2015;163:15-30
pubmed: 25468223
Tumour Biol. 2015 Feb;36(2):655-62
pubmed: 25283382
Cancer Cell. 2011 Jan 18;19(1):17-30
pubmed: 21251613
Cell Res. 2013 Aug;23(8):975-7
pubmed: 23732524
J Neurooncol. 2020 Feb;146(3):427-437
pubmed: 32020473
J Control Release. 2017 Sep 28;262:247-258
pubmed: 28687495
J Biol Chem. 2012 Jun 22;287(26):22408-17
pubmed: 22570471
N Engl J Med. 2009 Feb 19;360(8):765-73
pubmed: 19228619
Pharmacol Ther. 2015 Jul;151:16-31
pubmed: 25709099
Neuro Oncol. 2016 Jan;18(1):16-26
pubmed: 26188014
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
PLoS One. 2013;8(1):e54752
pubmed: 23349962
Biomed Res Int. 2016;2016:1450843
pubmed: 28097126